Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
marHRME for Esophageal Cancer Screening in Brazil
NCT05396781Phase 2Completed
- Start
- Jan 2022
- Primary completion
- Jan 2022
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial. Primary endpoints: Diagnostic yield at Day 1, Patient saved at Day 1 and 1 more. Started Jan 2022; status: completed.
Beyond the preview
Go deeper on NCT05396781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05396781.